Research Paper Volume 16, Issue 3 pp 2457—2474

MRPS23 is a novel prognostic biomarker and promotes glioma progression

class="figure-viewer-img"

Figure 2. MRPS23 expression correlated with the prognosis values of pan-cancer. (A) The OS for MRPS23 in glioma, HNSC, KICH, LIHC, OSCC and THCA. (B) The DSS for MRPS23 in glioma, HNSC, LIHC, KICH, KIRP, OSCC and OV. (C) The PFI for MRPS23 in ACC, glioma, HNSC, KICH, KIRP, LIHC and OSCC.